Sign in

CIK 0001253689

  • Non-accelerated filer
  • Smaller reporting company

CRESCENT BIOPHARMA, INC.

Sign in to watch
Ticker
CBIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Cayman Islands
Entity type
Operating
Phone
+1 617-430-5595
Business address
300 FIFTH AVENUE, WALTHAM, MA, 02451
Former names
GLYCOMIMETICS INC
  1. 4 Exercise or conversion Director acquired 21,000 shares (option exercise)
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Open-market sale SVP Finance, CFO sold 3,700 shares at $1.95 ($7,215)
  10. 4 Open-market buy Director bought 30,000 shares at $1.56 ($46,800)
  11. 4 Open-market buy SVP & Chief Commercial Officer bought 13,500 shares at $1.57 ($21,195)
  12. 3 Insider Initial Statement of Ownership
  13. 3 Insider Initial Statement of Ownership
  14. 4 Open-market buy 10% owner bought 100,000 shares at $1.70 ($170,000)
  15. 4 Open-market buy 10% owner bought 400,000 shares at an average $1.78 ($712,255)
  16. 4 Open-market buy 10% owner bought 1,515,266 shares at an average $2.00 ($3,027,929)
  17. 4 Open-market buy 10% owner bought 11,451 shares at $3.24 ($37,123)
  18. 3 Insider Initial Statement of Ownership
  19. 5 Insider Annual Insider Trading Report
  20. 4 Exercise or conversion Director acquired 10,500 shares (option exercise)

Page 5 of 15 · 293 filings